Diligence memo · auto-generated · as of July 3, 2026
Zandivio PLC
Zandivio PLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Zandivio PLC operates in Other Health Care, based in BARCELONA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Zandivio PLC has raised $17M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $17M on 2022-10-03.
Most recent recorded round closed around 2022-10-03.
Valuation (modeled)modeled
Provath models Zandivio PLC at approximately $188M (range $40M–$470M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.23× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 82% of Other Health Care peers (5377 compared).
Modeled value ranks above 87% of those peers.
Closest niche peers: Code Biotherapeutics, Inc., Candesant Biomedical, Inc., Artis Holdings, LLC, GIO Blood Ltd, Clarapath, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.